EFIC
CVS icon

Eliot Finkel Investment Counsel’s CVS Health CVS Stock Holding History

Eliot Finkel Investment Counsel’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-75,600
Closed -$5.28M – 31
2023
Q3 		$5.28M Buy
75,600
+140
+0.2% +$9.92K 3.55% 13
2023
Q2 		$5.22M Sell
75,460
-16,605
-18% -$1.18M 3.31% 15
2023
Q1 		$6.84M Buy
92,065
+5,347
+6% +$448K 4.36% 11
2022
Q4 		$8.08M Sell
86,718
-428
-0.5% -$41.3K 5.12% 4
2022
Q3 		$8.31M Sell
87,146
-30
-0% -$2.97K 6.15% 2
2022
Q2 		$8.08M Sell
87,176
-410
-0.5% -$40K 5.85% 3
2022
Q1 		$8.87M Sell
87,586
-1,304
-1% -$137K 5.23% 3
2021
Q4 		$9.17M Sell
88,890
-1,350
-1% -$125K 5.36% 4
2021
Q3 		$7.66M Buy
90,240
+5,250
+6% +$440K 4.91% 4
2021
Q2 		$7.09M Buy
84,990
+170
+0.2% +$13.9K 4.56% 7
2021
Q1 		$6.38M Sell
84,820
-306
-0.4% -$22.3K 4.11% 10
2020
Q4 		$5.81M Buy
85,126
+34,047
+67% +$2.21M 4.39% 10
2020
Q3 		$2.98M Sell
51,079
-25
-0% -$1.56K 2.66% 18
2020
Q2 		$3.32M Hold
51,104
– – 3.29% 15
2020
Q1 		$3.03M Sell
51,104
-950
-2% -$63.4K 3.31% 16
2019
Q4 		$3.87M Buy
52,054
+18,350
+54% +$1.29M 2.5% 21
2019
Q3 		$2.13M Sell
33,704
-560
-2% -$33.2K 1.52% 26
2019
Q2 		$1.87M Buy
34,264
+2,090
+6% +$113K 1.2% 32
2019
Q1 		$1.74M Buy
32,174
+1,005
+3% +$62K 1.15% 33
2018
Q4 		$2.04M Sell
31,169
-494
-2% -$36.9K 1.49% 30
2018
Q3 		$2.49M Buy
+31,663
New +$2.26M 1.59% 29

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eliot Finkel Investment Counsel's CVS Position: Q4 2023 in Review

Eliot Finkel Investment Counsel sold out of CVS Health (CVS) in Q4 2023, closing a stake of 75,600 shares — an estimated $5.28M sold.

Eliot Finkel Investment Counsel first reported a position in CVS in Q3 2018 and held it in 21 quarters. The position peaked at $9.17M in Q4 2021. 2,258 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Eliot Finkel Investment Counsel reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
  • Eliot Finkel Investment Counsel sold 75,600 CVS Health shares in Q4 2023, an estimated $5.28M.
  • Eliot Finkel Investment Counsel first reported a position in CVS Health in Q3 2018 and held it in 21 quarters.
  • Eliot Finkel Investment Counsel's CVS Health position peaked at $9.17M in Q4 2021.
  • 2,258 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Eliot Finkel Investment Counsel's 13F filing for Q4 2023, filed 18 Jan 2024.